v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
Product sales, net $ 176,243 $ 127,785 $ 336,125 $ 239,370
Operating expenses:        
Cost of sales 30,348 23,421 59,153 46,439
Research and development 90,528 46,067 188,438 87,111
Acquired in-process research and development 16,435 0 742,737 5,000
Selling, general and administrative 81,469 63,286 177,799 120,992
Total operating expenses 218,780 132,774 1,168,127 259,542
Loss from operations (42,537) (4,989) (832,002) (20,172)
Other income (expense):        
Interest income 3,851 3,033 7,252 6,056
Interest expense (2,618) (3,589) (6,234) (7,185)
Other (expense) income, net (24,234) 86 (24,234) 2,194
Net loss before provision for income taxes (65,538) (5,459) (855,218) (19,107)
Provision for income taxes 1,689 402 2,164 1,431
Net loss $ (67,227) $ (5,861) $ (857,382) $ (20,538)
Net loss per share, basic (in dollars per share) $ (1.06) $ (0.12) $ (14.03) $ (0.42)
Net loss per share, diluted (in dollars per share) $ (1.06) $ (0.12) $ (14.03) $ (0.42)
Weighted-average shares of common stock used to compute net loss per share, basic (in shares) 63,374,183 49,726,823 61,125,097 49,310,255
Weighted-average shares of common stock used to compute net loss per share, diluted (in shares) 63,374,183 49,726,823 61,125,097 49,310,255